Correction to: Longitudinal Characterization of Autoantibodies to the Thyrotropin Receptor (TRAb) During Alemtuzumab Therapy: Evidence that TRAb May Precede Thyroid Dysfunction by Many Years by Muller I, Willis M, Healy S, Nasser T, Loveless S, But

首页> 外文期刊>Thyroid: official journal of the American Thyroid Association >Correction to: Longitudinal Characterization of Autoantibodies to the Thyrotropin Receptor (TRAb) During Alemtuzumab Therapy: Evidence that TRAb May Precede Thyroid Dysfunction by Many Years by Muller I, Willis M, Healy S, Nasser T, Loveless S, But

【24h】

Correction to: Longitudinal Characterization of Autoantibodies to the Thyrotropin Receptor (TRAb) During Alemtuzumab Therapy: Evidence that TRAb May Precede Thyroid Dysfunction by Many Years by Muller I, Willis M, Healy S, Nasser T, Loveless S, But

机译：矫正：Alemtuzumab治疗期间对甲状腺激素受体（TRAB）的自身抗体的纵向表征：Carber Carrer在Muller I，Willis M，Healy S，Nasser T，无爱的，但是

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Thyroid: official journal of the American Thyroid Association》 |2019年第2期|共1页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类内分泌腺疾病及代谢病;
关键词

相似文献

外文文献

1. Correction to: Longitudinal Characterization of Autoantibodies to the Thyrotropin Receptor (TRAb) During Alemtuzumab Therapy: Evidence that TRAb May Precede Thyroid Dysfunction by Many Years by Muller I, Willis M, Healy S, Nasser T, Loveless S, But [J] . Thyroid: official journal of the American Thyroid Association . 2019,第2期

机译：矫正：Alemtuzumab治疗期间对甲状腺激素受体（TRAB）的自身抗体的纵向表征：Carber Carrer在Muller I，Willis M，Healy S，Nasser T，无爱的，但是
2. Longitudinal Characterization of Autoantibodies to the Thyrotropin Receptor During Alemtuzumab Therapy: Evidence that the Thyrotropin Receptor May Precede Thyroid Dysfunction by Many Years [J] . Muller Ilaria, Willis Mark, Healy Sarah, Thyroid: official journal of the American Thyroid Association . 2018,第12期

机译：Alemtuzumab治疗期间对甲状腺激素受体的自身抗体的纵向表征：证据表明甲状腺激素受体可能在多年内先服用甲状腺功能障碍
3. Correction to: Longitudinal Characterization of Autoantibodies to the Thyrotropin Receptor (TRAb) During Alemtuzumab Therapy: Evidence that TRAb May Precede Thyroid Dysfunction by Many Years by Muller I Willis M Healy S Nasser T Loveless S Butterworth S Zhang L Draman MS Taylor PN Robertson N Dayan CM and Ludgate ME. Thyroid 2018;28:1682–1693. DOI: 10.1089/thy.2018.0232 [O] . -1

机译：校正至：Alemtuzumab治疗期间对甲状腺促甲状腺素受体（TRAb）自身抗体的纵向表征：Muller IWillis MHealy SNasser TLoveless SButterworth SZhang L戏剧性的MS泰勒·PN罗伯逊·N达扬·CM和路德盖特·ME。甲状腺2018; 28：1682-1693。 DOI：10.1089 / thy.2018.0232
4. Correction to: Longitudinal Characterization of Autoantibodies to the Thyrotropin Receptor (TRAb) During Alemtuzumab Therapy: Evidence that TRAb May Precede Thyroid Dysfunction by Many Years by Muller I, Willis M, Healy S, Nasser T, Loveless S, Butterworth S, Zhang L, Draman MS, Taylor PN, Robertson N, Dayan CM, and Ludgate ME. Thyroid 2018;28:1682–1693. DOI: 10.1089/thy.2018.0232 [O] . 2019

机译：矫正：Alemtuzumab治疗期间甲状腺激素受体（Trab）的自身抗体的纵向表征：Carb的证据可以通过Muller I，Willis M，Healy S，Nasser T，Loveless S，Butterworth S，张L，Zhang Draman Ms，Taylor Pn，Robertson N，Dayan Cm，以及Ludgate Me。甲状腺2018; 28：1682-1693。 DOI：10.1089 / Thy.2018.0232

Correction to: Longitudinal Characterization of Autoantibodies to the Thyrotropin Receptor (TRAb) During Alemtuzumab Therapy: Evidence that TRAb May Precede Thyroid Dysfunction by Many Years by Muller I, Willis M, Healy S, Nasser T, Loveless S, But

著录项

相似文献

相关主题

期刊订阅